Latest Drug Approvals news
.jpg)
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Vyalev for Advanced Parkinson Disease
posted October 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease
posted October 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate 
Use of SAMA, SABA Linked to Cardiovascular Events, Mortality in Asthma, COPD 
Insurance Poses Barrier to Virtual Pulmonary Rehabilitation for COPD 
Higher Short-Term Exposure to Pollen Linked to Lower FEV1 in COPD Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
